CAR-T for Claudin18.2 Positive Solid Tumors

Clinical trial NCT07266311 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07266311
Sponsor: Chengdu Ucello Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Claudin18.2 Positive Advanced Solid Tumors

Start date: 2025-12-15
Primary completion: 2035-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.